Neelu Singh

Neelu Singh

Auto-generated profile, based on publicly available information

Neelu Singh

Stony Brook University 1 Stony Brook, NY

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
Priya SinghPriya Singh
Priya Singh
NSNeelu Singh
Neelu Singh
NMNidhi Mishra
Nidhi Mishra
RNRaquibun Nisha
Raquibun Nisha
ALAlka
Alka
SSShubhini A Saraf
Shubhini A Saraf

6 October 2019 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
NSNeelu Singh
Neelu Singh
MDMONOJ KUMAR DAS
MONOJ KUMAR DAS
RGRohit Gautam
Rohit Gautam
ARAnand Ramteke
Anand Ramteke
PRPaulraj Rajamani
Paulraj Rajamani

1 January 2020 in Toxicology Reports
Verified
Journal Article
Open access
NSNeelu Singh
Neelu Singh
MDMONOJ KUMAR DAS
MONOJ KUMAR DAS
ARAnand Ramteke
Anand Ramteke
PRPaulraj Rajamani
Paulraj Rajamani
Zinc oxide nanoparticles (ZNP) are being used in various fields viz cosmetics industry as UV protectants, in the food packaging industry due to their anti-bacterial properties, in agriculture as micronutrients, etc. Increased applications of ZNPs in our day to day life, leading to the contamination of the surrounding environment posing a direct or indirect health risk. Various reports suggest that fruits and vegetables are a rich source of phytochemicals having antioxidant properties which help in neutralizing ROS generated on metal toxicity of the body. The present study focuses to study the ameliorative effect of apple (Pyrus malus) extract (E) on ZNP induced toxicity. Therefore, animals were grouped, six in each, exposed to various doses of ZNP (50 and 250 mg/kg), ZNP (50 and 250 mg/kg)+E. The studied parameters was: food intake, water intake, antioxidants assay, zinc accumulation, and histological alterations and was compared to control. Investigation revealed that ZNP induces toxicity as revealed by the alteration in the studied parameter, whereas those exposed to ZNP along with Pyrus malus fruit extract try to reduce the toxicity induced by nanoparticles but at low doses only. This ameliorative effect of fruit extract might be due to the presence of antioxidants scavenging the free radicals generated by ZNPs suggesting that antioxidant-rich fruit may have a protective role and have the potential to reduce the nanoparticles mediated oxidative stress.

2 October 2026
Verified
Other
Open access
PDF file
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
SRSF1 protein levels remain unchanged following knockdown of USP9X or USP10.

11 June 2026 in Molecular Cancer Research
Verified
Journal Article
Closed access
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy primarily driven by oncogenic KRAS signaling. The splicing factor SRSF1 plays a key oncogenic role in PDAC through reciprocal cross-interactions with KRAS signaling. However, the mechanisms regulating SRSF1 protein stability remain poorly understood. Here, we identify the deubiquitinase USP39 as a critical regulator of SRSF1 stability. It interacts with SRSF1 in an RNA-independent manner and suppresses its ubiquitination. USP39 is upregulated in PDAC and correlates with poor patient prognosis. Functional analyses demonstrate that USP39 promotes PDAC cell progression, in part through stabilization of SRSF1. Mechanistically, MYC activates USP39 transcription through direct promoter binding. These findings define a MYC–USP39–SRSF1 regulatory axis that integrates transcriptional and post-translational mechanisms in PDAC and suggest USP39 as a potential therapeutic target. Implications: USP39 functions as a central regulator that integrates transcriptional and post-translational regulation in pancreatic cancer through the MYC–USP39–SRSF1 axis and represents a potential therapeutic target.

2 October 2026
Verified
Other
Open access
PDF file
BMBenteng Ma
Benteng Ma
XZXin Zhang
Xin Zhang
AKAlexander J. Kral
Alexander J. Kral
NSNeelu Singh
Neelu Singh
ADAstrid Deschênes
Astrid Deschênes
LWLedong Wan
Ledong Wan
MYC binds to the USP39 promoter.